Cargando…
A Retrospective Cohort Study of the Efficacy, Safety, and Clinical Value of 6-TG versus 6-MP Maintenance Therapy in Children with Acute Lymphoblastic Leukemia
OBJECTIVE: To explore the efficacy, safety, and clinical value of 6-TG versus 6-MP when treating childhood acute lymphoblastic leukemia (ALL). METHODS: The study period was from January 2017 to June 2021. The subjects of this study were 100 children with ALL who were treated in our hospital. Accordi...
Autores principales: | Tu, Minghui, Zhang, Aiming, Hu, Li, Wang, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420618/ https://www.ncbi.nlm.nih.gov/pubmed/36046443 http://dx.doi.org/10.1155/2022/7580642 |
Ejemplares similares
-
NUDT15 c.415C>T Polymorphism Predicts 6-MP Induced Early Myelotoxicity in Patients with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy
por: Pai, Aswin Anand, et al.
Publicado: (2021) -
Association of NUDT15 c.415C>T and FPGS 2572C>T Variants with the Risk of Early Hematologic Toxicity During 6-MP and Low-Dose Methotrexate-Based Maintenance Therapy in Indian Patients with Acute Lymphoblastic Leukemia
por: Kodidela, Sunitha, et al.
Publicado: (2020) -
EFFECT OF 6-MERCAPTOPURINE (6-MP) ON DIFFERENT CLASSES OF ANTIBODY
por: Borel, Yves, et al.
Publicado: (1965) -
PHF6 mutations in T-cell acute lymphoblastic leukemia
por: Van Vlierberghe, Pieter, et al.
Publicado: (2010) -
SUN-449 Medical versus Surgical Treatment of Macroprolactinomas (MP): Indications, Efficacy, and Safety
por: Cuccia, Mariela, et al.
Publicado: (2019)